Day: January 9, 2025

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), an industry leader in music and video content distribution, business services, and advertising solutions, is thrilled to announce that Samsung TV Karaoke, powered by the Stingray Karaoke app, has received the CES Innovation Award 2025 in the Content & Entertainment category. This award celebrates the innovative integration of the Stingray Karaoke app with Samsung’s 2025 TVs, providing an exceptional karaoke experience directly in consumers’ living rooms. The Samsung TV Karaoke feature revolutionizes home entertainment by offering the world’s first smart karaoke suite. This innovative solution eliminates the need for expensive microphones or sound systems. Users can simply sing into their mobile devices, and the app, driven by AI algorithms...

SANTA CLARA, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the fourth quarter 2024 after the close of market on Monday, Feb. 10, 2025. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call DetailsDate: Feb. 10, 2025   Time: 1:30 pm PT / 4:30 pm ET   Hosts: Jitendra Mohan, Chief Executive OfficerSanjay Gajendra, President and Chief Operating OfficerMike Tate, Chief Financial Officer   Dial-in: (800) 715-9871Conference ID: 5908687   Webcast: https://ir.asteralabs.com About Astera Labs Astera Labs is a global leader in purpose-built connectivity solutions...

PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) — Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the final Local Coverage Determination (LCD) of Genetic Testing for Oncology (L39365) issued by the Centers for Medicare & Medicaid Services (CMS). The new LCD establishes non-coverage for the Company’s widely used PancraGEN® test. PancraGEN is a DNA-based diagnostic molecular test. It uniquely assesses the risk of pancreatic cyst progression to cancer by integrating the results of first-line tests and procedures with molecular test results. It has been offered since 2013 and provides insight to physicians to aid their diagnosis of pancreatic cancer and help inform the optimal management of patients, including through the reduction of unnecessary surgeries. According...

BRISBANE, Australia, Jan. 10, 2025 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, announced today that it has entered into a licensing agreement with its long-time technology partner, Harper International Corporation (“Harper”), for the rights and use of its continuous, induction-based graphitization furnace technology. In December 2020, NOVONIX and Harper announced a strategic partnership to develop innovative graphitization furnace technology to be used to produce synthetic graphite anode material for the lithium-ion battery sector. This partnership provided for commitments from NOVONIX to purchase from Harper, and from Harper to develop and exclusively supply NOVONIX with proprietary systems for thermal processing material for the battery...

DALLAS, Jan. 09, 2025 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2024 before market on Thursday, January 23, 2025. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2024 operating results on Thursday, January 23, 2025, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting https://www.netroadshow.com/events/login?show=ce555c76&confId=76045 and will receive a unique PIN number to be used when dialing in for the call for immediate access. Alternatively, participants may call 833.470.1428 and use the access code 969515 at least fifteen minutes prior to the call to join through an operator. The live...

Inseego Wavemaker™ 5G Outdoor CPE FW3000 now available, certified on T-Mobile and US Cellular, for businesses seeking secure, reliable connectivity in both urban and rural areas SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) — Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, government and SMBs, today announced the launch of its next generation 5G outdoor CPE, the Inseego Wavemaker 5G Outdoor CPE FW3000. Designed to deliver reliable and secure 5G and LTE connectivity, the FW3000 is an ideal solution for businesses in both urban and rural areas and supports download speeds up to 5 Gbps, ensuring seamless video streaming, internet access, and more. Key Features of the Inseego Wavemaker 5G Outdoor CPE FW3000:High-Speed Connectivity: Supports...

DENVER, Jan. 09, 2025 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (NYSE: NBHC) expects to report its fourth quarter financial results after the markets close on Wednesday, January 22, 2025. Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Thursday, January 23, 2025. Interested parties may listen to this call by dialing (888) 394-8218 using the participant passcode of 9370973 and asking for the NBHC Q4 2024 Earnings Call. A recording of the call will be available approximately four hours after the call’s completion on the Company’s website at www.nationalbankholdings.com by visiting the investor relations area. About National Bank Holdings Corporation National Bank Holdings Corporation is a bank holding company created to build a leading community bank franchise delivering high...

LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading global therapeutics company (“the Company”) has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. This European-headquartered Company employs more than 20,000 people and operates in over 100 countries, with more than ten globally dispersed manufacturing sites. The Company provides supplies for companies working throughout the Life Sciences, including in research, clinical trials, manufacturing, diagnosis, and treatment. It also develops, produces, and provides innovative healthcare services and solutions to diagnose and treat a range of diseases, including rare conditions, for millions...